Pegah Nabavi

Pegah Nabavi is a seasoned formulation scientist currently employed at Recipharm, where responsibilities include formulation and manufacturing process development of drug products for clinical trials, particularly in sterile fill finish and oral solid dosage forms. Previous experience includes a role as a scientist in drug development at Nanologica AB, focusing on drug delivery formulations and project management for client products, and extensive research at Chalmers University of Technology, where contributions involved enzyme immobilization techniques and collaboration with Würzburg University. Pegah also held visiting researcher positions at several institutions, including the Julius Maximilians University of Würzburg and PicoQuant, and has a solid educational foundation with a PhD in Biophysical Chemistry from Chalmers University of Technology and an MSc in Biotechnology from Lund University.